ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rizzato, G
Right arrow Articles by Montemurro, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rizzato, G
Right arrow Articles by Montemurro, L
Eur Respir J 1993; 6: 116-119
Copyright © ERS Journals Ltd 1993

Original Articles

Reversibility of exogenous corticosteroid-induced bone loss

G Rizzato and L Montemurro

Osteoporosis is not usually considered to be reversible, as it is a consequence of the ageing process. However, an improvement of bone mineral density after successful surgery in Cushing's syndrome has been shown in several reports. The question of reversibility of exogenous corticosteroid-induced osteoporosis is, as yet, unanswered, possibly because of the difficulty in discontinuing steroids after long-term use. We describe six patients, all under 45 yrs of age, with chronic long-standing sarcoidosis, in whom long-term prednisone therapy resulted in 15 +/- 7% bone loss, as evaluated by quantitative computed tomography. This side-effect appeared fully reversible after prednisone withdrawal. This report of the reversibility of exogenous corticosteroid-induced bone loss needs confirmation in elderly people, where the capacity for recovery of bone mass could be reduced. Such potential for recovery may have implications for the pattern of use of corticosteroids.


This article has been cited by other articles:


Home page
 ChestHome page
O. Gluck and G. Colice
Recognizing and Treating Glucocorticoid-Induced Osteoporosis in Patients With Pulmonary Diseases
Chest, May 1, 2004; 125(5): 1859 - 1876.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
E. F. Dubois, E. Roder, P. N. R. Dekhuijzen, A. E. Zwinderman, and D. H. Schweitzer
Dual Energy X-ray Absorptiometry Outcomes in Male COPD Patients After Treatment With Different Glucocorticoid Regimens*
Chest, May 1, 2002; 121(5): 1456 - 1463.
[Abstract] [Full Text] [PDF]

Home page
 Am J Sports MedHome page
R. J. Clark, P. S. Sizer Jr., and J. Slauterbeck
Stress Fracture of the Ulna in a Male Competitive Polo Player
Am. J. Sports Med., January 1, 2002; 30(1): 130 - 132.
[Full Text] [PDF]

Home page
 J Intensive Care MedHome page
I. R. Reid
Glucocorticoid Osteoporosis: Reid IR Glucocorticoid osteoporosis J Intensive Care Med 1999, 14231-242
J Intensive Care Med, September 1, 1999; 14(5): 231 - 242.
[PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. Hunninghake
Statement on Sarcoidosis
Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 736 - 755.
[Full Text]

Home page
 BloodHome page
S. G. Shaughnessy, J. Hirsh, M. Bhandari, J. M. Muir, E. Young, and J. I. Weitz
A Histomorphometric Evaluation of Heparin-Induced Bone Loss After Discontinuation of Heparin Treatment in Rats
Blood, February 15, 1999; 93(4): 1231 - 1236.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G. Rizzato
Clinical impact of bone and calcium metabolism changes in sarcoidosis
Thorax, May 1, 1998; 53(5): 425 - 429.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the European Respiratory Society.